However, transgenic mice expressing human ACE2 are vulnerable to SARS-CoV-2 and can develop COVID-19 symptoms (Bao et al., 2020), suggesting that ACE2 is a sufficient receptor for SARS-CoV-2 attachment and cell entry. This evidence concerns the gene ACE2 and COVID-19.